In vivo, IDET significantly enhances the antitumor effects in a thyroid cancer xenograft mouse model, resulting in increased oxidative stress and apoptosis through inhibition of the p62‐Keap1‐Nrf2 pathway. The gene discussed is NFE2L2; the disease is thyroid gland carcinoma.